Global Gene Fragment Market Growth 2023-2029
The global Gene Fragment market size is projected to grow from US$ 258.1 million in 2022 to US$ 564.4 million in 2029; it is expected to grow at a CAGR of 11.8% from 2023 to 2029.
Global key players of gene fragment include Integrated DNA Technologies, Thermo Scientific and Eurofins Scientific, etc. The top five players hold a share over 40%. North America is the largest revenue market of gene fragment, holds a share over 40%, followed by Europe. In terms of type, the fragment that length of 1000 bp - 1999 bp is the largest segment, occupied for a share of 35. And in terms of application, CRISPR-based genome editing and antibody engineering each account for more than 30% of the market.
Gene fragments are pieces of genes containing only the exons (those parts of the gene which actually encode the protein sequence). They are composed of cDNA. Gene Fragment can be used in CRISPR-Based Genome Editing, Recombinant Antibody Engineering, cloning process, qPCR and PCR Controls, Enzyme Engineering, Vaccine Research, High Resolution Melt (HRM) Assays etc field.
LPI (LP Information)' newest research report, the “Gene Fragment Industry Forecast” looks at past sales and reviews total world Gene Fragment sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Fragment sales for 2023 through 2029. With Gene Fragment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Fragment industry.
This Insight Report provides a comprehensive analysis of the global Gene Fragment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Fragment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Gene Fragment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Fragment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Fragment.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Fragment market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
0-999 bp
1000-1999 bp
2000-3999 bp
4000+ bp
Segmentation by application
CRISPR-based Genome Editing
Antibody Engineering
Cloning Process
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Integrated DNA Technologies
Thermo Scientific
Eurofins Scientific
GenScript Biotech
Azenta Life Sciences
Twist Bioscience
Synbio Technologies
Bio Basic
BiOligo Biotechnology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Gene Fragment market?
What factors are driving Gene Fragment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gene Fragment market opportunities vary by end market size?
How does Gene Fragment break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.